1. Home
  2. Philanthropy & Grantmaking
  3. New York, NY
  4. Roivant Social Ventures

Roivant Social Ventures

Roivant Social Ventures is ranked #115 of 142 philanthropy & grantmaking organizations in New York, NY, with an America's Best Score of 64 out of 100, based on its 2025 Form 990.

  • New York, NY
  • Tax-exempt since 2020
  • EIN: 83-3947490
roivantsv.org ProPublica Charity Navigator
Is this your organization? Claim it Tax filings by year Nominate
64OF 100 #115 of 142 in New York ranked philanthropy & grantmaking organizations How this score is calculated

Organization summary

Roivant Social Ventures is a 501(c)(3) organization, classified under Philanthropy & Grantmaking (NTEE T30). Contributions are tax-deductible.

1 Pennsylvania Plaza 54Th Fl, New York, NY 10119-5501

Among the 221 scored philanthropy & grantmaking organizations in New York, Roivant Social Ventures holds 16.1 months of operating reserves (peer median 12.3 months), runs a typical yearly deficit of 9.3% (peers: surplus of 4.2%), and has grown spending 29.5% a year (peers: grown spending 6.6% a year).

In fiscal year 2025 it reported $306,829 in revenue and $287,235 in expenses, with contributions making up 99.4% of revenue.

Work here? Claim this profile to add your mission, programs and logo.

What it does

From its own Form 990, as filed with the IRS

Mission · 2025 Form 990

Promote systemic, sustained improvements to the way healthcare is accessed and delivered.

Main program · fiscal year 2023

  • The organization had the following initiatives for the fiscal-year ending March 31, 2023: (I)launched partnership with the university of North Carolina at chapel hill, eshelman center for innovation, on our initiative to improve diversity in senior leadership in the biopharma industry. The first step in this partnership involved a spring 2023 "making medicines" class, co-taught by rsv president an… Read more

    The organization had the following initiatives for the fiscal-year ending March 31, 2023: (I)launched partnership with the university of North Carolina at chapel hill, eshelman center for innovation, on our initiative to improve diversity in senior leadership in the biopharma industry. The first step in this partnership involved a spring 2023 "making medicines" class, co-taught by rsv president and CEO lindsay androski that featured industry leaders as guest speakers. The class was coupled with paid summer internship opportunities for talented students interested in a career in biopharma. (II)launched partnership with vanderbilt university's drug repurposing program, focused on development of existing "shelved" drugs for unmet patient needs. (III)became a founding member of carer (catalyzing access to research and equity in representation), which has developed a "clinical trial diversity scorecard." the scorecard grades biopharma companies that receive new drug approvals from the fda by evaluating how well the company represented the real-world patient population (based on sex, age, ethnicity, and race) in its pivotal clinical trial. In the future, we intend to give awards to the companies that best represent real-world patients in their clinical trials.

    $35,997 spent

Where each dollar went · fiscal year 2025

Of every dollar it spent, 57¢ went to programs, 35¢ to management and 8¢ to fundraising.

  • Programs $163,370
  • Management $99,855
  • Fundraising $24,010

In the organization's own words to the IRS, shown for context. None of this affects the America's Best Score, and a Form 990 describes programs without measuring their results.

America's Best Score

Free assessmentMethodology
Score64 / 100
Rank in New York#115 of 142
DesignationRanked

Score breakdown

MeasureThis organizationPoints
Operating reserves16.1 mo; 16.7 mo in cash11.2 / 25
Financial balance (median margin)−9.3%5 / 20
Transparency4 full 990s, latest TY202520 / 20
Program growth+29.5% / yr15 / 15
Track record6 years2.4 / 10
Debt load5.9% of assets10 / 10
Total63.6 → 64
Spending on programs
Not scored; America's Best needs 65%+
57%Below

Compared with New York peers

MeasureThis organizationPeer median
Operating reserves16.1 mo12.3 mo
Typical margin−9.3%+4.2%
Spending growth+29.5% / yr+6.6% / yr
Debt load5.9%3.7%

Peers: the 221 New York philanthropy & grantmaking organizations with a score, ranked or below the bar.

Tax filings by year

Financial data extracted from the Form 990 the organization filed with the IRS for each fiscal year. Revenue lines can exceed 100% when other items, such as fundraising event costs, are netted against total revenue.

Revenue$306,829Fiscal year 20252022: $693,79220222023: $183,09320232024: $123,89320242025: $306,8292025
Expenses$287,235Fiscal year 20252022: $132,27720222023: $245,56020232024: $254,63720242025: $287,2352025
Total assets$408,573Fiscal year 20252022: $838,06420222023: $755,91820232024: $627,35120242025: $408,5732025
Total liabilities$24,000Fiscal year 20252022: $276,30620222023: $256,62720232024: $258,80420242025: $24,0002025
Fiscal year ending March 2025
Revenue$306,829
Expenses$287,235
Net income$19,594
Net assets$384,573

Notable sources of revenue

Percent of total revenue
Contributions$305,032
Program services$0
Investment income$1,797
Other (net)$0

Assets / debt

Total assets$408,573
Total liabilities$24,000
Net assets$384,573

Compensation

Not in our extract for this year.

Fiscal year ending March 2024
Revenue$123,893
Expenses$254,637
Net income−$130,744
Net assets$368,547

Notable sources of revenue

Percent of total revenue
Contributions$110,143
Program services$0
Investment income$13,750
Other (net)$0

Assets / debt

Total assets$627,351
Total liabilities$258,804
Net assets$368,547

Compensation

Not in our extract for this year.

Fiscal year ending March 2023
Revenue$183,093
Expenses$245,560
Net income−$62,467
Net assets$499,291

Notable sources of revenue

Percent of total revenue
Contributions$170,136
Program services$0
Investment income$12,957
Other (net)$0

Assets / debt

Total assets$755,918
Total liabilities$256,627
Net assets$499,291

Compensation

Not in our extract for this year.

Fiscal year ending March 2022
Revenue$693,792
Expenses$132,277
Net income$561,515
Net assets$561,758

Notable sources of revenue

Percent of total revenue
Contributions$684,276
Program services$0
Investment income$9,516
Other (net)$0

Assets / debt

Total assets$838,064
Total liabilities$276,306
Net assets$561,758

Compensation

Officers and key employees$0
Share of expenses0.0%

About this data

Figures come from IRS Form 990 filings, through the IRS Exempt Organizations Business Master File (2026-11-09) and e-filed returns. Form 990 data typically lags 12–24 months behind an organization's fiscal year. Found an error?